Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Fuller, Clifton D."" wg kryterium: Autor


Tytuł:
Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio.
Autorzy:
Rooney MK; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Andring LM; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Corrigan KL; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Bernard V; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Williamson TD; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Fuller CD; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Garden AS; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Gunn B; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Lee A; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Moreno AC; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Morrison WH; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Phan J; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Rosenthal DI; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Spiotto M; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Frank SJ; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Aug 29; Vol. 15 (17). Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity.
Autorzy:
Hemmati M; Computational Applied Mathematics and Operations Research, William Marsh Rice University, Houston, Texas, USA.
Barbon C; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
van Dijk LV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Radiation Oncology, University Medical Center- Groningen, Groningen, Netherlands.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Schaefer AJ; Computational Applied Mathematics and Operations Research, William Marsh Rice University, Houston, Texas, USA.
Fuller CD; Computational Applied Mathematics and Operations Research, William Marsh Rice University, Houston, Texas, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Pokaż więcej
Corporate Authors:
MD Anderson Head and Neck Cancer Symptom Working Group
Źródło:
Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (4), pp. 5088-5098. Date of Electronic Publication: 2022 Oct 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Robotic Surgical Procedures*/adverse effects
Robotic Surgical Procedures*/methods
Oropharyngeal Neoplasms*/therapy
Oropharyngeal Neoplasms*/etiology
Head and Neck Neoplasms*/etiology
Humans ; Deglutition ; Squamous Cell Carcinoma of Head and Neck
Czasopismo naukowe
Tytuł:
Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors.
Autorzy:
Aggarwal P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nader ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gidley PW; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pratihar R; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jivani S; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mott FE; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ogboe CW; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Charles C; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Shete S; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 569-583. Date of Electronic Publication: 2022 Jun 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Tinnitus*/epidemiology
Tinnitus*/etiology
Hearing Loss*/epidemiology
Hearing Loss*/etiology
Oropharyngeal Neoplasms*/complications
Oropharyngeal Neoplasms*/therapy
Humans ; Quality of Life ; Survivors
Czasopismo naukowe
Tytuł:
Estimating the optimal linear combination of predictors using spherically constrained optimization.
Autorzy:
Das P; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. .
De D; Indian Statistical Institute, Kolkata, India.
Maiti R; Centre for Quantitative Medicine, Duke-National University of Singapore Medical School, Singapore, Singapore.
Kamal M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chakraborty B; Centre for Quantitative Medicine, Duke-National University of Singapore Medical School, Singapore, Singapore.; Department of Statistics and Applied Probability, National University of Singapore, Singapore, Singapore.; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2022 Oct 19; Vol. 23 (Suppl 3), pp. 436. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Algorithms*
ROC Curve ; Computer Simulation ; Biomarkers
Czasopismo naukowe
Tytuł:
Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study.
Autorzy:
Ng SP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.; Department of Radiation Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne, VIC 3071, Australia.; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Cardenas CE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Bahig H; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 3E4, Canada.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.; Department of Clinical Oncology and Nuclear Medicine, Mansoura University, Mansoura 35516, Egypt.
Wang J; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Johnson JM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Shah SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Ding Y; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Na L; Department of Biostatistics, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Urbauer D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
MacManus MP; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77098, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Aug 31; Vol. 29 (9), pp. 6303-6313. Date of Electronic Publication: 2022 Aug 31.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/diagnostic imaging
Head and Neck Neoplasms*/radiotherapy
Biomarkers ; Diffusion Magnetic Resonance Imaging/methods ; Humans ; Magnetic Resonance Imaging
Czasopismo naukowe
Tytuł:
Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors.
Autorzy:
Aggarwal P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yu R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wang J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rigert J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mott FE; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lu C; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chambers MS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Li G; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wu CC; Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX, USA.
Shete S; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Apr 22; Vol. 12 (1), pp. 6662. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Head and Neck Neoplasms*/genetics
Oropharyngeal Neoplasms*/genetics
Xerostomia*/genetics
Cancer Survivors ; Genetic Predisposition to Disease ; Humans ; Microfilament Proteins ; Patient Reported Outcome Measures ; Receptors, Cell Surface
Czasopismo naukowe
Tytuł:
MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers.
Autorzy:
Mulder SL; Department of Radiation Oncology, The University of Texas at MD Anderson Cancer Center, Houston, TX 77030, USA.
Heukelom J; Department of Radiation Oncology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
McDonald BA; Department of Radiation Oncology, The University of Texas at MD Anderson Cancer Center, Houston, TX 77030, USA.
Van Dijk L; Department of Radiation Oncology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
Wahid KA; Department of Radiation Oncology, The University of Texas at MD Anderson Cancer Center, Houston, TX 77030, USA.
Sanders K; Department of Radiation Oncology, The University of Texas at MD Anderson Cancer Center, Houston, TX 77030, USA.
Salzillo TC; Department of Radiation Oncology, The University of Texas at MD Anderson Cancer Center, Houston, TX 77030, USA.
Hemmati M; Department of Computational and Applied Mathematics, Rice University, Houston, TX 77005, USA.
Schaefer A; Department of Computational and Applied Mathematics, Rice University, Houston, TX 77005, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas at MD Anderson Cancer Center, Houston, TX 77030, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Apr 10; Vol. 14 (8). Date of Electronic Publication: 2022 Apr 10.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Author Correction: Radiomics feature stability of open-source software evaluated on apparent diffusion coefficient maps in head and neck cancer.
Autorzy:
Korte JC; Department of Physical Science, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. .; Department of Biomedical Engineering, University of Melbourne, Melbourne, Australia. .
Cardenas C; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, USA.
Hardcastle N; Department of Physical Science, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia.; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
Kron T; Department of Physical Science, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Wang J; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, USA.
Bahig H; Radiation Oncology Department, Centre Hospitalier de l'Université de Montréal, Montreal, Canada.
Elgohari B; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Clinical Oncology & Nuclear Medicine Department, Mansoura University, Mansoura, Egypt.
Ger R; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Court L; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, USA.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
Ng SP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Melbourne, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Sep 17; Vol. 11 (1), pp. 18908. Date of Electronic Publication: 2021 Sep 17.
Typ publikacji:
Published Erratum
Tytuł:
Radiomics feature stability of open-source software evaluated on apparent diffusion coefficient maps in head and neck cancer.
Autorzy:
Korte JC; Department of Physical Science, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia. .; Department of Biomedical Engineering, University of Melbourne, Melbourne, Australia. .
Cardenas C; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, USA.
Hardcastle N; Department of Physical Science, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia.; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
Kron T; Department of Physical Science, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Wang J; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, USA.
Bahig H; Radiation Oncology Department, Centre Hospitalier de l'Université de Montréal, Montreal, Canada.
Elgohari B; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Clinical Oncology & Nuclear Medicine Department, Mansoura University, Mansoura, Egypt.
Ger R; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Court L; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, USA.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
Ng SP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Melbourne, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Sep 03; Vol. 11 (1), pp. 17633. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Head/*diagnostic imaging
Head and Neck Neoplasms/*diagnostic imaging
Image Processing, Computer-Assisted/*methods
Neck/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Biomarkers ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Reproducibility of Results ; Software
Czasopismo naukowe
Tytuł:
Oropharyngeal cancer patient stratification using random forest based-learning over high-dimensional radiomic features.
Autorzy:
Patel H; Department of Electrical and Computer Engineering, University of Iowa, Iowa City, 52242, USA.
Vock DM; Division of Biostatistics, University of Minnesota, Minneapolis, 55455, USA.
Marai GE; Department of Department of Computer Science, University of Illinois at Chicago, Chicago, 60607, USA.
Fuller CD; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, 77030, USA.
Mohamed ASR; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, 77030, USA.
Canahuate G; Department of Electrical and Computer Engineering, University of Iowa, Iowa City, 52242, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jul 07; Vol. 11 (1), pp. 14057. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Diagnostic Imaging*/methods
Diagnostic Imaging*/standards
Image Processing, Computer-Assisted*/methods
Oropharyngeal Neoplasms/*diagnostic imaging
Oropharyngeal Neoplasms/*mortality
Aged ; Algorithms ; Area Under Curve ; Cluster Analysis ; Computational Biology/methods ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Staging ; Oropharyngeal Neoplasms/pathology ; Prognosis ; Software
Czasopismo naukowe
Tytuł:
Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.
Autorzy:
Smith GL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fu S; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ning MS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nguyen DK; University of California Riverside School of Medicine, Riverside, CA, USA.
Busse PM; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Foote RL; Department of Radiation Oncology, Mayo Clinic and Mayo Clinic School of Medicine and Science, Rochester, MN, USA.
Garden AS; Willis-Knighton Proton Therapy Center, Shreveport, LA, USA.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chronowski GM; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mayo LL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Snider JW 3rd; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Patel SH; Department of Radiation Oncology, Mayo Clinic and Mayo Clinic School of Medicine and Science, Phoenix, AZ, USA.
Katz SR; Willis-Knighton Proton Therapy Center, Shreveport, LA, USA.
Lin A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Mohammed N; Northwestern Medicine Chicago Proton Center, Warrenville, IL, USA.
Dagan R; Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło:
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 319-327. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer.
Autorzy:
Bahig H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Centre Hospitalier de l'Université de Montréal, Montreal, Canada.
Gunn BG; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ye R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson K; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ng SP; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Peter MacCallum Cancer Center, Melbourne, Australia.
Gross ND; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sturgis EM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillison M; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło:
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 213-222. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Transparency in reporting of phase 3 cancer clinical trial results.
Autorzy:
Patel RR; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.; Albany Medical College, Albany, NY, USA.
Verma V; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Fuller CD; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
McCaw ZR; Google, Mountain View, CA, USA.
Ludmir EB; The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Feb; Vol. 60 (2), pp. 191-194. Date of Electronic Publication: 2020 Dec 13.
Typ publikacji:
Letter
MeSH Terms:
Neoplasms*/therapy
Research Design*
Clinical Trials as Topic ; Humans
Opinia redakcyjna
Tytuł:
Ultra-small superparamagnetic iron oxide (USPIO) magnetic resonance imaging in benign mixed tumor of the parotid gland.
Autorzy:
Johnson JM; Department of Diagnostic Radiology The University of Texas MD Anderson Cancer Center Houston TX USA.
Mohamed ASR; Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston TX USA.
Ding Y; Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston TX USA.
Wang J; Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston TX USA.
Lai SY; Department of Head & Neck Surgery The University of Texas MD Anderson Cancer Center Houston TX USA.
Fuller CD; Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston TX USA.
Shah R; Department of Diagnostic Radiology The University of Texas MD Anderson Cancer Center Houston TX USA.
Butler RT; Department of Pathology The University of Texas MD Anderson Cancer Center Houston TX USA.
Weber RS; Department of Head & Neck Surgery The University of Texas MD Anderson Cancer Center Houston TX USA.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2020 Dec 09; Vol. 9 (1), pp. 123-127. Date of Electronic Publication: 2020 Dec 09 (Print Publication: 2021).
Typ publikacji:
Case Reports
Raport
Tytuł:
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
Autorzy:
Elhalawani H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elgohari B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Lin TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Sikora AG; ENT Section, Operative Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.; Bobby R. Alford Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, One Baylor Plaza, MS: NA102, Houston, TX, 77030, USA.
Lai SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abusaif A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, 0097, FCT10.6002, Houston, TX, 77030, USA. .; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA. .
Sandulache VC; ENT Section, Operative Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. .; Bobby R. Alford Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, One Baylor Plaza, MS: NA102, Houston, TX, 77030, USA. .; Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Sep 23; Vol. 20 (1), pp. 912. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell/*etiology
Carcinoma, Squamous Cell/*mortality
Oropharyngeal Neoplasms/*etiology
Oropharyngeal Neoplasms/*mortality
Papillomavirus Infections/*mortality
Smoking/*mortality
Alphapapillomavirus/isolation & purification ; Carcinoma, Squamous Cell/epidemiology ; Carcinoma, Squamous Cell/pathology ; Female ; Humans ; Male ; Middle Aged ; Oropharyngeal Neoplasms/pathology ; Oropharyngeal Neoplasms/virology ; Papillomavirus Infections/pathology ; Retrospective Studies ; Smoking/pathology ; Survival Analysis
Czasopismo naukowe
Tytuł:
Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer.
Autorzy:
Bogowicz M; University Hospital Zurich and University of Zurich, Department of Radiation Oncology, Zurich, Switzerland. .; GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre-, Department of Precision Medicine, The D Lab: Decision Support for Precision Medicine-, Maastricht, The Netherlands. .
Jochems A; GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre-, Department of Precision Medicine, The D Lab: Decision Support for Precision Medicine-, Maastricht, The Netherlands.
Deist TM; GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre-, Department of Precision Medicine, The D Lab: Decision Support for Precision Medicine-, Maastricht, The Netherlands.
Tanadini-Lang S; University Hospital Zurich and University of Zurich, Department of Radiation Oncology, Zurich, Switzerland.
Huang SH; Princess Margaret Cancer Center- University of Toronto, Department of Radiation Oncology, Toronto, Ontario, Canada.
Chan B; Princess Margaret Cancer Center- University of Toronto, Department of Radiation Oncology, Toronto, Ontario, Canada.
Waldron JN; Princess Margaret Cancer Center- University of Toronto, Department of Radiation Oncology, Toronto, Ontario, Canada.
Bratman S; Princess Margaret Cancer Center- University of Toronto, Department of Radiation Oncology, Toronto, Ontario, Canada.
O'Sullivan B; Princess Margaret Cancer Center- University of Toronto, Department of Radiation Oncology, Toronto, Ontario, Canada.
Riesterer O; University Hospital Zurich and University of Zurich, Department of Radiation Oncology, Zurich, Switzerland.; Kantonsspital Aarau, Center for Radiation Oncology- KSA-KSB-, Aarau, Switzerland.
Studer G; University Hospital Zurich and University of Zurich, Department of Radiation Oncology, Zurich, Switzerland.; Cantonal Hospital Lucerne, Radiation Oncology, Lucerne, Switzerland.
Unkelbach J; University Hospital Zurich and University of Zurich, Department of Radiation Oncology, Zurich, Switzerland.
Barakat S; GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre-, Department of Precision Medicine, The D Lab: Decision Support for Precision Medicine-, Maastricht, The Netherlands.
Brakenhoff RH; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Otolaryngology/Head and Neck Surgery, Amsterdam, The Netherlands.
Nauta I; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Otolaryngology/Head and Neck Surgery, Amsterdam, The Netherlands.
Gazzani SE; Parma University Hospital, Radiology Department, Parma, Italy.
Calareso G; IRCCS Fondazione Istituto Nazionale dei Tumori, Radiology Department, Milan, Italy.
Scheckenbach K; University Hospital Duesseldorf, Heinrich-Heine-University, Department of Otorhinolaryngology & Head/Neck, Surgery, Duesseldorf, Germany.
Hoebers F; Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre, Department of Radiation Oncology, Maastricht, The Netherlands.
Wesseling FWR; Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre, Department of Radiation Oncology, Maastricht, The Netherlands.
Keek S; GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre-, Department of Precision Medicine, The D Lab: Decision Support for Precision Medicine-, Maastricht, The Netherlands.
Sanduleanu S; GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre-, Department of Precision Medicine, The D Lab: Decision Support for Precision Medicine-, Maastricht, The Netherlands.
Leijenaar RTH; GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre-, Department of Precision Medicine, The D Lab: Decision Support for Precision Medicine-, Maastricht, The Netherlands.
Vergeer MR; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.
Leemans CR; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Otolaryngology/Head and Neck Surgery, Amsterdam, The Netherlands.
Terhaard CHJ; University Medical Center Utrecht, Department of Radiotherapy, Utrecht, The Netherlands.
van den Brekel MWM; The Netherlands Cancer Institute, Department of Head and Neck Oncology and Surgery, Amsterdam, The Netherlands.
Hamming-Vrieze O; The Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, The Netherlands.
van der Heijden MA; The Netherlands Cancer Institute, Department of Head and Neck Oncology and Surgery, Amsterdam, The Netherlands.
Elhalawani HM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Guckenberger M; University Hospital Zurich and University of Zurich, Department of Radiation Oncology, Zurich, Switzerland.
Lambin P; GROW-School for Oncology and Developmental Biology-Maastricht University Medical Centre-, Department of Precision Medicine, The D Lab: Decision Support for Precision Medicine-, Maastricht, The Netherlands.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Mar 11; Vol. 10 (1), pp. 4542. Date of Electronic Publication: 2020 Mar 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Data Accuracy*
Deep Learning*
Privacy*
Head and Neck Neoplasms/*mortality
Papillomaviridae/*isolation & purification
Papillomavirus Infections/*complications
Tomography, X-Ray Computed/*methods
Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/virology ; Humans ; Image Interpretation, Computer-Assisted ; Papillomavirus Infections/virology ; Prognosis ; ROC Curve ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging.
Autorzy:
Jin Y; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Randall JW; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; The University of Texas Medical Branch, Galveston, TX 77555, USA.
Elhalawani H; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Feghali KAA; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Elliott AM; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Anderson BM; Department of Imaging Physics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Lacerda L; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Tran BL; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mohamed AS; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Brock KK; Department of Imaging Physics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Fuller CD; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Chung C; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Feb 29; Vol. 12 (3). Date of Electronic Publication: 2020 Feb 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients.
Autorzy:
Ger RB; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Zhou S; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Elgohari B; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Elhalawani H; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Mackin DM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Meier JG; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Nguyen CM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Anderson BM; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Gay C; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Ning J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Fuller CD; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Li H; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Howell RM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Layman RR; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Mawlawi O; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Stafford RJ; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Aerts H; Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Court LE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Sep 19; Vol. 14 (9), pp. e0222509. Date of Electronic Publication: 2019 Sep 19 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Head and Neck Neoplasms/*mortality
Head and Neck Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Positron-Emission Tomography/methods ; Proportional Hazards Models ; Retrospective Studies ; Tomography, X-Ray Computed/methods ; Young Adult
Czasopismo naukowe
Tytuł:
Effects of alterations in positron emission tomography imaging parameters on radiomics features.
Autorzy:
Ger RB; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Meier JG; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Pahlka RB; Department of Radiology, Texas Children's Hospital, Houston, Texas, United States of America.
Gay S; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Mumme R; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Fuller CD; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Li H; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Howell RM; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Layman RR; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Stafford RJ; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Zhou S; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Mawlawi O; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Court LE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Sep 05; Vol. 14 (9), pp. e0221877. Date of Electronic Publication: 2019 Sep 05 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Algorithms*
Phantoms, Imaging*
Carcinoma, Non-Small-Cell Lung/*diagnostic imaging
Image Processing, Computer-Assisted/*methods
Lung Neoplasms/*diagnostic imaging
Positron-Emission Tomography/*methods
Adult ; Aged ; Aged, 80 and over ; Female ; Fluorodeoxyglucose F18 ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Radiopharmaceuticals ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing.
Autorzy:
Zaid M; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Bajaj N; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Burrows H; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Mathew R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Dai A; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Wilke CT; Department of Radiation Oncology, University of Minnesota Medical School, 516 Delaware St SE, Minneapolis, MN, 55455, USA.
Palasi S; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Hergenrother R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Chung C; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Fuller CD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Garden AS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Frank SJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA.
Andersen M; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Otun A; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Chambers MS; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Koay EJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0097, Houston, TX, 77030, USA. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2019 Aug 19; Vol. 14 (1), pp. 148. Date of Electronic Publication: 2019 Aug 19.
Typ publikacji:
Journal Article
MeSH Terms:
Stents*
Head and Neck Neoplasms/*radiotherapy
Printing, Three-Dimensional/*instrumentation
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*instrumentation
Tomography, X-Ray Computed/*methods
Adult ; Aged ; Dental Impression Technique ; Female ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Models, Dental ; Prognosis ; Radiotherapy Dosage ; Reproducibility of Results ; Retrospective Studies ; Workflow
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies